Profound Medical (PROF) Long-Term Debt Repayments (2024 - 2025)

Profound Medical (PROF) recorded quarterly Long-Term Debt Repayments of $290000.0 in Q1 2025, up 82.39% quarter-over-quarter from $159000.0 in Q4 2024, and down 53.45% on a YoY basis from $623000.0 in Q1 2024.

Profound Medical (PROF) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends

Profound Medical's Long-Term Debt Repayments history runs 2 years deep, the most recent figure standing at $290000.0 for Q1 2025.

  • In Q1 2025, Long-Term Debt Repayments fell 53.45% year-over-year to $290000.0; the TTM figure through Dec 2025 stood at $290000.0 (down 85.34% YoY), while the FY2025 annual figure was $290000.0, down 85.34% from the prior year.
  • Long-Term Debt Repayments was $290000.0 for Q1 2025 at Profound Medical, up from $159000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $623000.0 in Q1 2024 to a low of $159000.0 in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.42 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 1.00 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Profound Medical 240.29 Mn 190.00 Mn 3.83 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 290,000.00
Mar 31, 2025 290,000.00
Dec 31, 2024 159,000.00
Dec 31, 2024 159,000.00
Sep 30, 2024 592,000.00
Sep 30, 2024 592,000.00
Jun 30, 2024 604,000.00
Jun 30, 2024 604,000.00
Mar 31, 2024 623,000.00
Mar 31, 2024 623,000.00